M. Leuck et al. / Tetrahedron Letters 45 (2004) 321–324
323
Table 1. 50-Phosphorylated oligonucleotides 10–12 prepared with the phosphoramidite reagent 1
Oligonucleotide
AX-HPLCa
Purity (%)
MALDI–MS
Found
OD260
Rt (min)
Calculated
50-p-d(TTT TTT TTT T) 10
50-p-d(CTC TCA GCG AGC CTC AA) 11
50-p-d(TTG AGG CTC GCT GAG AG) 12
15.62b
9.93c
9.63c
90.8
83.1
67.6
3059.9
5192.3
5343.9
3065.4
5188.7
5328.8
79.1
125.7
116.4
a Anion exchange HPLC conditions: Dionex DNAPac PA100 column (4 · 250 mm) eluting with a linear gradient at 85 ꢁC with a flow rate of 1.5 mL/
min, detection at k ¼ 260 nm, buffer A ¼ 25 mM trizma hydrochloride/1 mM EDTA/10%CH3CN, pH 7.5, buffer B ¼ 25 mM trizma hydrochloride/
1 mM EDTA/10%CH3CN/1 M NaCl, pH 7.5.
b Gradient 1: 10–46% buffer B in 22.00 min.
c Gradient 2: 36–80% buffer B in 22.00 min.
poured into stirred hexanes (500 mL) to give a colorless
precipitate that was filtered and dried to provide 4.35 g
(62%) of the carbonate 5 as a colorless powder.
the controlled pore glass (CPG) support containing the
oligonucleotide were treated with concd ammonia
solution or with AMA solution (concd ammonia/40% aq
methylamine 1/1, v/v) using various temperatures and
times. Anion exchange HPLC analysis of the ammonia
solutions indicated that complete deprotection was
achieved within 2 h in concd ammonia at 55 ꢁC or within
15 min in AMA solution at 65 ꢁC.
9. The carbonate 5 (4.15 g, 5.85 mmol) was dissolved in
CH2Cl2 (15 mL) and added dropwise to a stirred and ice-
cooled solution of 1,3-diaminopropane (2.16 g, 29.3 mmol)
and triethylamine (4.1 mL, 29.3 mmol) in CH2Cl2 (50 mL).
The mixture was stirred at room temperature overnight,
then diluted with CH2Cl2 (100 mL) and washed with aq
satd NaHCO3 solution (5 · 100 mL) and brine (100 mL).
The organic phase was dried over Na2SO4, filtered and
concentrated to provide a yellow foam, which was purified
via flash chromatography eluting with CH2Cl2/EtOH/
Et3N 80:15:5 (v/v/v) to give 2.60 g (69%) of the amine 6 as
a colorless amorphous solid. Rf 0.08 (CH2Cl2/EtOH/Et3N
80:15:5, v/v/v). 1H NMR (CD3CN, 300 MHz): d 7.50–7.41
(m, 3H), 7.38–7.25 (m, 7H), 6.90 (d, J ¼ 8:8 Hz, 4H), 6.26
(dd, J ¼ 5:9, 2.6 Hz, 1H), 6.10–6.04 (m, 1H), 5.35–5.29 (m,
1H), 4.08 (d, J ¼ 2:6 Hz, 1H), 3.85 (br s, 2H), 3.78 (s, 6H),
3.40 (dd, J ¼ 10:5, 3.4 Hz, 1H), 3.31 (dd, J ¼ 10:5, 2.9 Hz,
1H), 3.16 (q, J ¼ 6:5 Hz, 2H), 2.65 (t, J ¼ 6:7 Hz, 2H),
2.50–2.30 (m, 2H), 1.57 (quintet, J ¼ 6:7 Hz, 2H), 1.42 (s,
3H). 13C NMR (CD3CN, 75 MHz): d 164.0, 159.0, 156.1,
150.8, 145.0, 136.0, 135.8, 130.3, 128.3, 128.2, 127.3, 113.4,
110.9, 86.9, 84.4, 84.2, 75.2, 64.0, 55.2, 38.7, 38.3, 37.6,
32.2, 11.4.
In conclusion, the novel phosphoramidite 1, prepared in
five steps from a common thymidine intermediate, is
employed as an efficient reagent for the 50-phosphoryl-
ation of oligonucleotides. The reagentꢀs appearance as a
solid foam is advantageous for its manipulation and
handling in solid-phase synthesis and improves its
thermal stability.
References and Notes
1. (a) Wosnick, M. A.; Barnett, R. W.; Vicentini, A. M.;
Erfle, H.; Elliott, R.; Sumner-Smith, M.; Mantei, N.;
Davies, R. W. Gene 1987, 60, 115–127; (b) Carter, J. B.;
Pulaski, S. P.; Theriault, N. Y. BioTechniques 1988, 6,
470–474.
10. Nozaki, S. Chem. Lett. 1997, 1–2.
11. Ethyl (R)-4-cyano-3-hydroxybutanoate
7
(0.702 g,
2. Barany, F. PCR Meth. Appl. 1991, 1, 5–16.
3. Landegren, U.; Kaiser, R.; Sanders, J.; Hood, L. Science
1988, 241, 1077–1080.
4. (a) Chu, B. C. F.; Wahl, G. M.; Orgel, L. E. Nucl. Acids
Res. 1983, 11, 6513–6529; (b) Fedorova, O. S.; Savitskii,
A. P.; Shoikhet, K. G.; Ponomarev, G. V. FEBS Lett.
1990, 259, 335–337.
5. (a) Horn, T.; Urdea, M. S. Tetrahedron Lett. 1986, 27,
4705–4708; (b) Horn, T.; Allen, J. S.; Urdea, M. S.
Nucleosides Nucleotides 1987, 6, 335–340.
€
6. (a) Guzaev, A.; Salo, H.; Azhayev, A.; Lonnberg, H.
Tetrahedron 1995, 51, 9375–9384; (b) Guzaev, A.;
4.47 mmol) was treated with 1 M NaOH (9 mL, 9 mmol)
and the resulting mixture was stirred at room temperature
for 2 h. 1.5 M NaH2PO4 (9 mL) was added and the pH of
the solution was adjusted to 5.7 with concd HCl. After
addition of HOBtÆH2O (70 mg, 0.46 mmol) and DMF
(9 mL) the mixture was treated with a solution of the amine
6 (1.35 g, 2.09 mmol) in THF (4 mL). The pH was again
adjusted to 6.0 with diluted HCl (concd HCl/water 1:10, v/
v) and EDC (0.801 g, 4.18 mmol) was added. The reaction
mixture was stirred overnight, then diluted with water
(100 mL) and extracted with EtOAc (3 · 50 mL). The
organic phase was dried over Na2SO4 and concentrated.
The crude product was purified via flash chromatogra-
phy eluting with EtOAc/hexanes/acetonitrile 70:25:5 (v/v/
v) to provide 1.01 g (64%) of alcohol 9 as a colorless foam.
€
Lonnberg, H. Tetrahedron 1999, 55, 9101–9116.
7. A similar reaction to prepare compound 5 is described by
Li, H.; Miller, M. J. Tetrahedron Lett. 2000, 41, 4323–
4327.
Rf
0.43
(EtOAc/hexanes/EtOH
70:25:5,
v/v/v)
8. 50-O-DMT-thymidine 4 (5.02 g, 9.22 mmol) was co-eva-
porated with pyridine (2 · 20 mL), dissolved in pyridine
(25 mL) and treated dropwise under ice cooling with a
solution of 4-nitrophenyl chloroformate (1.95 g,
9.68 mmol) in CH2Cl2 (25 mL). The mixture was stirred
overnight at room temperature. The solution was concen-
trated to dryness and the remainder was redissolved in
CH2Cl2 (20 mL). This solution was added slowly to
vigorously stirred diethyl ether (150 mL). The resulting
precipitate was filtered off and discarded. The filtrate was
1H NMR (CD3CN, 300 MHz): d 9.09 (br s, 1H), 7.50–
7.40 (m, 3H), 7.38–7.23 (m, 7H), 6.90 (d, J ¼ 8:8 Hz, 4H),
6.68–6.61 (m, 1H), 6.27 (dd, J ¼ 6:2, 2.3 Hz, 1H), 5.86
(t, J ¼ 6:2 Hz, 1H), 5.34–5.28 (m, 1H), 4.19 (quintet,
J ¼ 6:5 Hz, 1H), 4.12–4.08 (m, 1H), 3.78 (s, 6H), 3.41 (dd,
J ¼ 10:5, 3.4 Hz, 1H), 3.32 (dd, J ¼ 10:5, 2.9 Hz, 1H),
3.20 (quintet, J ¼ 6:4 Hz, 2H), 3.11 (dt, J ¼ 7:2, 6.4 Hz,
2H), 2.63 (dd, J ¼ 16:8, 5.0 Hz, 1H), 2.53 (dd, J ¼ 16:8,
6.2 Hz, 1H), 2.45–2.30 (m, 4H), 2.18 (s, 1H), 1.61 (quintet,
J ¼ 6:4 Hz, 2H), 1.43 (s, 3H). 13C NMR (CD3CN,